| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in operating activities | -13,036 | -22,721 |
| Purchases of property and equipment | 0 | 0 |
| Net cash used in investing activities | 0 | 0 |
| Proceeds from exercise of stock options | 0 | 0 |
| Payment of debt amendment fees | 0 | 0 |
| Repayment of debt | 11,919 | 8,029 |
| Repayment of finance lease | 277 | 183 |
| Payment of equity issuance costs | 0 | - |
| Net cash used in financing activities | -12,196 | -8,212 |
| Net decrease in cash and cash equivalents | -25,232 | -30,933 |
| Cash and cash equivalents at end of period | 21,097 | - |
Verrica Pharmaceuticals Inc. (VRCA)
Verrica Pharmaceuticals Inc. (VRCA)